BrightBid Group AB (publ) (PERP-B) - Net Assets

Latest as of March 2026: Skr28.54 Million SEK ≈ $3.07 Million USD

Based on the latest financial reports, BrightBid Group AB (publ) (PERP-B) has net assets worth Skr28.54 Million SEK (≈ $3.07 Million USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Skr58.98 Million ≈ $6.35 Million USD) and total liabilities (Skr30.44 Million ≈ $3.28 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. See PERP-B net asset quality score to measure how much of total assets are equity-financed.

Key Net Assets Metrics

Metric Value
Current Net Assets Skr28.54 Million
% of Total Assets 48.39%
Annual Growth Rate 16.87%
5-Year Change 47.72%
10-Year Change 2235.23%
Growth Volatility 205.4

BrightBid Group AB (publ) - Net Assets Trend (2012–2025)

This chart illustrates how BrightBid Group AB (publ)'s net assets have evolved over time, based on quarterly financial data. For live market cap and overall valuation, see PERP-B stock market capitalisation.

Annual Net Assets for BrightBid Group AB (publ) (2012–2025)

The table below shows the annual net assets of BrightBid Group AB (publ) from 2012 to 2025. Also explore PERP-B net assets growth trend to track the company's year-over-year net asset growth rate.

Year Net Assets Change
2025-12-31 Skr30.77 Million
≈ $3.31 Million
+183.22%
2024-12-31 Skr10.87 Million
≈ $1.17 Million
+34.63%
2023-12-31 Skr8.07 Million
≈ $868.57K
-42.48%
2022-12-31 Skr14.03 Million
≈ $1.51 Million
-32.65%
2021-12-31 Skr20.83 Million
≈ $2.24 Million
+39.18%
2020-12-31 Skr14.97 Million
≈ $1.61 Million
-12.10%
2019-12-31 Skr17.03 Million
≈ $1.83 Million
+24.07%
2018-12-31 Skr13.72 Million
≈ $1.48 Million
+22.10%
2017-12-31 Skr11.24 Million
≈ $1.21 Million
+752.96%
2016-12-31 Skr1.32 Million
≈ $141.82K
-76.18%
2015-12-31 Skr5.53 Million
≈ $595.30K
-9.67%
2014-12-31 Skr6.12 Million
≈ $659.05K
+45.47%
2013-12-31 Skr4.21 Million
≈ $453.06K
+3.77%
2012-12-31 Skr4.06 Million
≈ $436.60K
--

Equity Component Analysis

This analysis shows how different components contribute to BrightBid Group AB (publ)'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 0.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2025)

Component Amount Percentage
Common Stock Skr1.08 Million 5.49%
Other Components Skr18.68 Million 94.51%
Total Equity Skr19.76 Million 100.00%

BrightBid Group AB (publ) Competitors by Market Cap

The table below lists competitors of BrightBid Group AB (publ) ranked by their market capitalization.

Company Market Cap
NT Minerals Ltd
AU:NTM
$2.57 Million
VCI Global Limited Ordinary Share
NASDAQ:VCIG
$2.57 Million
Afentra PLC
LSE:AET
$2.58 Million
Arkha Jayanti Persada PT
JK:ARKA
$2.58 Million
Foresight VCT PLC
LSE:FTV
$2.57 Million
Ramsdens Holdings PLC
LSE:RFX
$2.57 Million
Northern Lion Gold Corp
V:NL
$2.56 Million
Dolfines SAS
PA:ALDOL
$2.56 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in BrightBid Group AB (publ)'s equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2024 to 2025, total equity changed from 7,845,898 to 19,762,000, a change of 11,916,102 (151.9%).
  • Net income of 2,452,000 contributed positively to equity growth.
  • Other factors increased equity by 9,464,102.

Equity Change Factors (2024 to 2025)

Factor Impact Contribution
Net Income Skr2.45 Million +12.41%
Other Changes Skr9.46 Million +47.89%
Total Change Skr- 151.88%

Book Value vs Market Value Analysis

This analysis compares BrightBid Group AB (publ)'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 0.66x
  • The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
  • The price-to-book ratio has increased from 0.18x to 0.66x over the analyzed period, suggesting growing market confidence.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2012-12-31 Skr15.64 Skr2.79 x
2013-12-31 Skr12.56 Skr2.79 x
2014-12-31 Skr18.27 Skr2.79 x
2015-12-31 Skr2.95 Skr2.79 x
2016-12-31 Skr0.65 Skr2.79 x
2017-12-31 Skr3.92 Skr2.79 x
2018-12-31 Skr1.99 Skr2.79 x
2019-12-31 Skr1.58 Skr2.79 x
2020-12-31 Skr1.06 Skr2.79 x
2021-12-31 Skr1.08 Skr2.79 x
2022-12-31 Skr0.80 Skr2.79 x
2023-12-31 Skr0.49 Skr2.79 x
2024-12-31 Skr1.74 Skr2.79 x
2025-12-31 Skr4.24 Skr2.79 x

Capital Efficiency Dashboard

This dashboard shows how efficiently BrightBid Group AB (publ) utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 12.41%
  • The company shows good efficiency in utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 16.84%
  • • Asset Turnover: 0.23x
  • • Equity Multiplier: 3.15x
  • Recent ROE (12.41%) is above the historical average (-135.11%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2012 -17.70% -338.68% 0.04x 1.48x Skr-1.12 Million
2013 -46.42% -221.70% 0.14x 1.49x Skr-1.84 Million
2014 -17.26% -104.04% 0.13x 1.26x Skr-1.67 Million
2015 -135.02% -3083.76% 0.03x 1.35x Skr-8.02 Million
2016 -852.70% -80459.69% 0.00x 4.65x Skr-11.37 Million
2017 -88.47% -1245.60% 0.05x 1.37x Skr-11.07 Million
2018 -90.24% -1196.62% 0.06x 1.30x Skr-13.76 Million
2019 -98.25% -766.68% 0.11x 1.19x Skr-18.43 Million
2020 -97.46% -767.39% 0.10x 1.27x Skr-16.08 Million
2021 -65.82% -155.54% 0.34x 1.23x Skr-15.80 Million
2022 -136.58% -189.48% 0.54x 1.34x Skr-20.57 Million
2023 -226.45% -183.95% 0.81x 1.53x Skr-19.08 Million
2024 -31.52% -35.64% 0.37x 2.39x Skr-3.26 Million
2025 12.41% 16.84% 0.23x 3.15x Skr475.80K

Industry Comparison

This section compares BrightBid Group AB (publ)'s net assets metrics with peer companies in the Medical Devices industry.

Industry Context

  • Industry: Medical Devices
  • Average net assets among peers: $506,247,030
  • Average return on equity (ROE) among peers: -29.90%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
BrightBid Group AB (publ) (PERP-B) Skr28.54 Million -17.70% 1.07x $2.57 Million
Abbott Laboratories (ABT) $4.82 Billion 39.04% 1.31x $177.99 Billion
Adagio Medical Holdings, Inc Common Stock (ADGM) $-132.02 Million 0.00% 0.00x $11.08 Million
Aethlon Medical Inc (AEMD) $4.89 Million -146.36% 0.30x $1.02 Million
Acutus Medical Inc (AFIB) $126.58 Million -80.56% 0.52x $903.35K
Adapthealth Corp (AHCO) $245.55 Million 0.85% 0.03x $800.36 Million
20/20 Biolabs, Inc. Common Stock (AIDX) $6.89 Million 30.07% 0.49x $4.97 Million
Allurion Technologies, Inc. (ALUR) $-34.28 Million 0.00% 0.00x $1.16 Million
Autonomix Medical, Inc. Common Stock (AMIX) $8.10 Million -140.88% 0.21x $4.00 Million
Artivion Inc (AORT) $7.30 Million 9.59% 0.70x $1.16 Billion
Apyx Medical Inc (APYX) $9.29 Million -10.75% 0.15x $126.79 Million

About BrightBid Group AB (publ)

ST:PERP-B USA Medical Devices
Market Cap
$2.57 Million
Skr23.87 Million SEK
Market Cap Rank
#29792 Global
#6067 in USA
Share Price
Skr2.79
Change (1 day)
+1.09%
52-Week Range
Skr2.56 - Skr5.56
All Time High
Skr5.56
About

Perpetua Medical AB (publ) provides products and solutions for use of injectable drugs in Sweden. It provides DrugLog, a solution for reducing medication errors in pharmacy; WasteLog, a device that analysis waste and returns of injectable controlled substances; and PrepLog, a DrugLog based technology platform that integrated prescription software or medication management system for the test of dr… Read more